PubMed

High incidence of severe cyclosporine neurotoxicity in children affected by haemoglobinopaties undergoing myeloablative haematopoietic stem cell transplantation: early diagnosis and prompt intervention ameliorates neurological outcome.

Noè A, Cappelli B, Biffi A, Chiesa R, Frugnoli I, Biral E, Finizio V, Baldoli C, Vezzulli P, Minicucci F, Fanelli G, Fiori R, Ciceri F, Roncarolo MG, Marktel S.

Ital J Pediatr. 2010 Feb 6;36(1):14.PMID: 20181110 [PubMed - in process]Free PMC ArticleFree textRelated citations

[A clinical analysis of severe cyclosporine A-related neurotoxicity after allogenic hematopoietic stem cell transplantation]

Luo XD, Liu QF, Ning J, Fan ZP, Xu D, Wei YQ.

Zhonghua Nei Ke Za Zhi. 2008 Jan;47(1):40-3. Chinese. PMID: 18346325 [PubMed - indexed for MEDLINE]Related citations

[Unrelated donor stem cell transplantation in children: low toxicity using a GvHD-prophylaxis regimen with CSA, MTX, metronidazole,iv-immunoglobulin and ATG]

Graf Finckenstein F, Zabelina T, Dürken M, Dahlke J, Kröger N, Krüger W, Janka-Schaub G, Erttmann R, Zander AR, Kabisch H.

Klin Padiatr. 2002 Jul-Aug;214(4):206-11. German. PMID: 12165903 [PubMed - indexed for MEDLINE]Related citations

Low incidence of acute graft-versus-host disease and recurrent leukaemia in patients undergoing allogeneic haemopoietic stem cell transplantation from sibling donors with methotrexate and dose-monitored cyclosporin A prophylaxis.

Byrne JL, Stainer C, Hyde H, Miflin G, Haynes AP, Bessell EM, Russell NH.

Bone Marrow Transplant. 1998 Sep;22(6):541-5.PMID: 9758340 [PubMed - indexed for MEDLINE]Free ArticleRelated citations

[Quadruple therapy with CsA, MTX, MMF and ATG for preventing graft-versus-host disease in unrelated donor hematopoietic stem cell transplantation]

Liu QF, Sun J, Zhang Y, Xu D, Liu XL, Xu B, Meng FY, Zhou SY.

Di Yi Jun Yi Da Xue Xue Bao. 2003 Nov;23(11):1143-5. Chinese. PMID: 14625172 [PubMed - indexed for MEDLINE]Related citations

CsA-associated neurotoxicity and ineffective prophylaxis with clonazepam in patients transplanted for thalassemia major: analysis of risk factors.

Erer B, Polchi P, Lucarelli G, Angelucci E, Baronciani D, Galimberti M, Giardini C, Gaziev D, Maiello A.

Bone Marrow Transplant. 1996 Jul;18(1):157-62.PMID: 8832009 [PubMed - indexed for MEDLINE]Related citations

Clinical findings and magnetic resonance imaging in severe cyclosporine-related neurotoxicity after allogeneic bone marrow transplantation.

Trullemans F, Grignard F, Van Camp B, Schots R.

Eur J Haematol. 2001 Aug;67(2):94-9.PMID: 11722596 [PubMed - indexed for MEDLINE]Related citations

Hematopoietic stem cell transplantation for high-risk adult patients with severe aplastic anemia; reduction of graft failure by enhancing stem cell dose.

Min CK, Kim DW, Lee JW, Han CW, Min WS, Kim CC.

Haematologica. 2001 Mar;86(3):303-10.PMID: 11255278 [PubMed - indexed for MEDLINE]Free ArticleRelated citations

Allogeneic hematopoietic cell transplantation without myeloablative conditioning for patients with advanced hematologic malignancies.

Gürman G, Arat M, Ilhan O, Konuk N, Beksaç M, Celebi H, Ozcan M, Arslan O, Ustün C, Akan H, Uysal A, Koç H.

Cytotherapy. 2001;3(4):253-60.PMID: 12171713 [PubMed - indexed for MEDLINE]Related citations

Achievement of target cyclosporine concentrations as a predictor of severe acute graft versus host disease in children undergoing hematopoietic stem cell transplantation and receiving cyclosporine and methotrexate prophylaxis.

Punnett A, Sung L, Price V, Das P, Diezi M, Doyle J, Dupuis LL.

Ther Drug Monit. 2007 Dec;29(6):750-7.PMID: 18043472 [PubMed - indexed for MEDLINE]Related citations

Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.

Petersen SL.

Dan Med Bull. 2007 May;54(2):112-39. Review.PMID: 17521527 [PubMed - indexed for MEDLINE]Related citations

Microangiopathy following allogeneic marrow transplantation. Association with cyclosporine and methylprednisolone for graft-versus-host disease prophylaxis.

Kalhs P, Brugger S, Schwarzinger I, Greinix HT, Keil F, Kyrle PA, Knöbl P, Schneider B, Höcker P, Linkesch W, et al.

Transplantation. 1995 Nov 15;60(9):949-57.PMID: 7491699 [PubMed - indexed for MEDLINE]Related citations

Allogeneic peripheral blood stem cell transplantation in patients with early-phase hematologic malignancy: a retrospective comparison of short-term outcome with bone marrow transplantation.

Lemoli RM, Bandini G, Leopardi G, Rosti G, Bonini A, Fortuna A, Rondelli D, Mangianti S, Motta MR, Rizzi S, Tassi C, Cavo M, Remiddi C, Curti A, Conte R, Tura S.

Haematologica. 1998 Jan;83(1):48-55.PMID: 9542323 [PubMed - indexed for MEDLINE]Free ArticleRelated citations

Standard versus alternative myeloablative conditioning regimens in allogeneic hematopoietic stem cell transplantation for high-risk acute leukemia.

Mengarelli A, Iori A, Guglielmi C, Romano A, Cerretti R, Torromeo C, Micozzi A, Fenu S, Laurenti L, Donato V, De Felice L, Arcese W.

Haematologica. 2002 Jan;87(1):52-8.PMID: 11801465 [PubMed - indexed for MEDLINE]Free ArticleRelated citations

[Hematopoietic stem cell transplantation for patients with chronic myelogenous leukemia]

Liu QF, Sun J, Zhang Y, Liu XL, Xu D, Xu B, Feng R, Meng FY, Zhou SY.

Ai Zheng. 2004 Apr;23(4):426-9. Chinese. PMID: 15087032 [PubMed - indexed for MEDLINE]Free ArticleRelated citations

Sequential intensified conditioning and tapering of prophylactic immunosuppressants for graft-versus-host disease in allogeneic hematopoietic stem cell transplantation for refractory leukemia.

Liu QF, Fan ZP, Zhang Y, Jiang ZJ, Wang CY, Xu D, Sun J, Xiao Y, Tan H.

Biol Blood Marrow Transplant. 2009 Nov;15(11):1376-85. Epub 2009 Aug 19.PMID: 19822296 [PubMed - indexed for MEDLINE]Related citations

[Mycophenolate mofetil in treatment of graft-versus-host disease after allogeneic hematopoietic cell transplantation: analysis of 44 cases]

Chen H, Liu KY, Liu DH, Xu LP, Han W, Chen YH, Huang XJ.

Zhonghua Yi Xue Za Zhi. 2008 Aug 5;88(30):2127-30. Chinese. PMID: 19080474 [PubMed - indexed for MEDLINE]Related citations

Early and late neurological complications after reduced-intensity conditioning allogeneic stem cell transplantation.

Barba P, Piñana JL, Valcárcel D, Querol L, Martino R, Sureda A, Briones J, Delgado J, Brunet S, Sierra J.

Biol Blood Marrow Transplant. 2009 Nov;15(11):1439-46. Epub 2009 Sep 1.PMID: 19822304 [PubMed - indexed for MEDLINE]Related citations

A fludarabine-based dose-reduced conditioning regimen followed by allogeneic stem cell transplantation from related or unrelated donors in patients with myelodysplastic syndrome.

Kröger N, Schetelig J, Zabelina T, Krüger W, Renges H, Stute N, Schrum J, Kabisch H, Siegert W, Zander AR.

Bone Marrow Transplant. 2001 Oct;28(7):643-7.PMID: 11704786 [PubMed - indexed for MEDLINE]Free ArticleRelated citations

Graft-versus-host disease prophylaxis with tacrolimus and mycophenolate mofetil in HLA-matched nonmyeloablative transplant recipients is associated with very low incidence of GVHD and nonrelapse mortality.

Sabry W, Le Blanc R, Labbé AC, Sauvageau G, Couban S, Kiss T, Busque L, Cohen S, Lachance S, Roy DC, Roy J.

Biol Blood Marrow Transplant. 2009 Aug;15(8):919-29. Epub 2009 Jun 10.PMID: 19589481 [PubMed - indexed for MEDLINE]Related citations